Adan Jaramillo joins Sonoma Biotherapeutics with over 18 years of biotechnology and pharmaceutical quality experience from clinical and commercial companies.
Prior to joining Sonoma Bio, Jaramillo was Head of Global QA Operations at Juno Therapeutics, a Bristol Myers Squibb company. In that role, he was responsible for leading quality oversight of Contract Manufacturers of Cell Products and Global Patient Operations. Over his seven years there, he held various leadership roles within the company in diverse quality functions including Quality Systems, Manufacturing QA Operations, and Supplier Quality. Prior to Juno, Jaramillo worked for Shire, Dendreon and Amgen.
Throughout his career, Jaramillo has developed quality programs to support the clinical development, product approval and commercialization of cellular immunotherapies including Breyanzi®, Abecma®, and Provenge®.
Adan graduated from the University of Southern California with a degree in Biology with an emphasis in Molecular and Cell Biology. Fight on!